The Ghrelin/LEAP2 symposium brings together researchers and clinicians from all over the world for a one-day symposium dedicated to the exploration of one of the body’s most intriguing hormones. The symposium will be held as a satellite meeting of the 11th International Congres of Neuroendocrinology (ICN 2026), in Nagoya Winc Aichi, at the Aichi Industry and Labor Center on July 25th.

Attendees will gain a broad overview of the latest discoveries, including emerging evidence of ghrelin and its antagonist LEAP2’s impact on neuroendocrine functions, metabolism, feeding behaviors and reward and their potential as a therapeutic target in treating metabolic, eating and addictive disorders.

In addition to invited lectures by leading experts in the field, the symposium will foster an environment in which trainees and young investigators could exchange ideas and get feedback from senior leading experts through oral and poster sessions.

As Japan is the country in which ghrelin was identified, this is a unique opportunity to celebrate more than 25 years of research on ghrelin biology.

Winc Aichi Center, Aichi Industry and Labor Center, Nagoya